Dalian Bio-Chem Company603360.SHValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 19, 2026, Dalian Bio-Chem Company (603360.SH) trades at a P/E of 46.00x, P/B of 5.80x, P/S of 6.96x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 85th percentile over the trailing 10Y window (vs. 57th percentile over 3Y); P/B sits at the 68th percentile over the trailing 10Y window (vs. 34th percentile over 3Y); P/S sits at the 58th percentile over the trailing 10Y window (vs. 32nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 61st percentile within its industry and the 58th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.96%, ranking at the 81st percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 17.0 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. Dalian Bio-Chem Company operates in the Basic Chemical Engineering sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHA: 603360 · SSE: 603360 · 603360
Want the full picture on whether Dalian Bio-Chem Company (603360.SH) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 46.00 | ||||||
| P/B (MRQ) | 5.80 | ||||||
| P/S (TTM) | 6.96 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 4.96% |